Boris Peaker
Stock Analyst at TD Cowen
(1.79)
# 3,130
Out of 4,761 analysts
22
Total ratings
33.33%
Success rate
5.39%
Average return
Main Sectors:
Stocks Rated by Boris Peaker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AADI Aadi Bioscience | Downgrades: Hold | n/a | $2.79 | - | 2 | Aug 21, 2024 | |
| GLYC GlycoMimetics | Downgrades: Hold | n/a | $0.29 | - | 1 | Jul 26, 2024 | |
| MGNX MacroGenics | Downgrades: Hold | n/a | $2.76 | - | 3 | May 10, 2024 | |
| LNTH Lantheus Holdings | Initiates: Outperform | $100 | $78.23 | +27.83% | 1 | Dec 4, 2023 | |
| ADCT ADC Therapeutics | Downgrades: Market Perform | n/a | $1.63 | - | 1 | Nov 9, 2023 | |
| PCRX Pacira BioSciences | Upgrades: Outperform | $50 | $25.16 | +98.73% | 1 | Aug 3, 2023 | |
| PCVX Vaxcyte | Initiates: Outperform | n/a | $79.74 | - | 1 | Apr 18, 2023 | |
| XNCR Xencor | Initiates: Outperform | n/a | $15.74 | - | 1 | Dec 6, 2022 | |
| EBS Emergent BioSolutions | Maintains: Market Perform | $30 → $29 | $7.71 | +276.13% | 1 | Sep 12, 2022 | |
| CTMX CytomX Therapeutics | Downgrades: Market Perform | n/a | $0.78 | - | 2 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $95 → $102 | $89.50 | +13.97% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.93 | - | 1 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.09 | - | 1 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.17 | - | 1 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $13.15 | - | 1 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.77 | - | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $0.53 | - | 1 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $644.48 | - | 1 | Jun 12, 2017 |
Aadi Bioscience
Aug 21, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.79
Upside: -
GlycoMimetics
Jul 26, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.29
Upside: -
MacroGenics
May 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.76
Upside: -
Lantheus Holdings
Dec 4, 2023
Initiates: Outperform
Price Target: $100
Current: $78.23
Upside: +27.83%
ADC Therapeutics
Nov 9, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.63
Upside: -
Pacira BioSciences
Aug 3, 2023
Upgrades: Outperform
Price Target: $50
Current: $25.16
Upside: +98.73%
Vaxcyte
Apr 18, 2023
Initiates: Outperform
Price Target: n/a
Current: $79.74
Upside: -
Xencor
Dec 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $15.74
Upside: -
Emergent BioSolutions
Sep 12, 2022
Maintains: Market Perform
Price Target: $30 → $29
Current: $7.71
Upside: +276.13%
CytomX Therapeutics
Jul 11, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $0.78
Upside: -
Jun 27, 2022
Maintains: Market Perform
Price Target: $95 → $102
Current: $89.50
Upside: +13.97%
Mar 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $0.93
Upside: -
Mar 3, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.09
Upside: -
Aug 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.17
Upside: -
Jul 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $13.15
Upside: -
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $1.77
Upside: -
Jul 24, 2017
Initiates: Outperform
Price Target: n/a
Current: $0.53
Upside: -
Jun 12, 2017
Initiates: Outperform
Price Target: n/a
Current: $644.48
Upside: -